Expression of vascular endothelial growth factor receptor-3 in the endometrium in menorrhagia
Vascular endothelial growth factor receptor-3 expression in endometrial capillaries and arterioles was increased in women with idiopathic menorrhagia compared to controls.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This study investigated vascular endothelial growth factor receptor-3 (VEGFR-3) expression in endometrial tissue, comparing 24 patients with idiopathic menorrhagia (IM) to 18 healthy, fertile women using immunohistochemistry and image analysis of VEGFR-3 and CD34-stained endothelial structures. VEGFR-3 expression was weak to moderate in endometrial stroma and glands across the menstrual cycle in both groups, with capillaries showing markedly higher expression than arterioles and venules, and no menstrual-cycle–related differences between patients and controls. The key finding was that vascular VEGFR-3 expression was higher in IM, including a 1.6-fold increase in the number of VEGFR-3–positive capillaries per mm² and a 2.0-fold increase in VEGFR-3–positive arterioles. The limitation explicitly noted by the study design is that it compares IM to healthy controls without functional validation of how VEGFR-3 drives angiogenesis. This paper is centrally about endometriosis—association context is provided via a statement that disrupted angiogenesis may lead to endometriosis, while the study’s actual experimental focus is idiopathic menorrhagia and VEGFR-3 in endometrium.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
4,011 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
Cited by (4)
- Enhanced expressions of matrix metalloproteinase (MMP)-2 and –9 and vascular endothelial growth factors (VEGF) and increased microvascular density in the endometrial hyperplasia of women with anovulatory dysfunctional uterine bleeding 2009
- Low pericyte coverage of endometrial microvessels in heavy menstrual bleeding correlates with the microvessel expression of VEGF-A 2014
- Circulating Vascular Endothelial Growth Factor and Soluble fms-Like Tyrosine Kinase-1 as Biomarkers for Endometrial Remodeling Across the Menstrual Cycle 2020
- Hysterectomy and levonorgestrel-releasing intrauterine system in the treatment of menorrhagia : a 10-year randomized comparative trial 2012
References (14)
- Microvascular density, vascular endothelial growth factor A, and its receptors in endometrial blood vessels in patients with menorrhagia via openalex
- W1982017077 via openalex
- W2000292756 via openalex
- W2025933554 via openalex
- W2026642794 via openalex
- W2044175751 via openalex
- W2063449125 via openalex
- W2065081355 via openalex
- W2132961183 via openalex
- W2138779548 via openalex
- W2141827022 via openalex
- W4229618597 via openalex
- W1783580437 via openalex
- W4255318861 via openalex
Cited by (4)
- Circulating Vascular Endothelial Growth Factor and Soluble fms-Like Tyrosine Kinase-1 as Biomarkers for Endometrial Remodeling Across the Menstrual Cycle 2020
- Low pericyte coverage of endometrial microvessels in heavy menstrual bleeding correlates with the microvessel expression of VEGF-A 2014
- Hysterectomy and levonorgestrel-releasing intrauterine system in the treatment of menorrhagia : a 10-year randomized comparative trial 2012
- Enhanced expressions of matrix metalloproteinase (MMP)-2 and –9 and vascular endothelial growth factors (VEGF) and increased microvascular density in the endometrial hyperplasia of women with anovulatory dysfunctional uterine bleeding 2009
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:15:00.519696+00:00